Molecular therapy for Stroke: Lithium, a mood stabilizing agent used in the treatment of Bipolar disorder, augments regenerative neurogenesis after Ischemic Stroke and ameliorates stroke damage and neurological deficits via up regulation of its target gene NAMPT, 27/April/2017, 3.19 pm

Natural product therapy for Diabetic nephropathy (DN): Berberine, an isoquinoline alkaloid isolated from Berberis, Phellodendron amurense, Guduchi (Tinospora cordifolia/Amirthavalli), and Argemone mexicana among others, increases Pyruvate kinase M2 (PKM2) expression, decreases toxic glucose metabolites, mitochondrial dysfunction and apoptosis, augments glycolytic flux and PGC-1α levels, improves metabolic abnormalities, albuminuria, glomerular pathology, and renal dysfunction and alleviates diabetic nephropathy via down regulation of its target gene, 27/April/2017, 9.56 am
April 27, 2017
Molecular therapy for Regenerating the lost pancreatic β-cells in Diabetic patients: Serotonin reuptake inhibitor (SRI) antidepressant Fluoxetine (Trade names: Prozac and Sarafem) increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state via up-regulation of its target gene Lin28, 27/April/2017, 6.58 pm
April 27, 2017
Show all

Introduction: What they say

A recent study from From the Department of Pharmacology, Second Military Medical University, Shanghai, China; Department of Science and Education, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China; and Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China (C.-Y.M.) shows that “Regenerative Neurogenesis After Ischemic Stroke Promoted by Nicotinamide Phosphoribosyltransferase-Nicotinamide Adenine Dinucleotide Cascade” This study was published in the June 9 2015 issue of the journal Stroke  by Prof  Miao CY, Zhao Y, and others.


What we say

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Molecular therapy for Stroke: Lithium, a mood stabilizing agent used in the treatment of Bipolar disorder,  augments regenerative neurogenesis after Ischemic Stroke and ameliorates stroke damage and neurological deficits via up regulation of its target gene NAMPT.

price-200


From research findings to therapeutic opportunity: 

Figure 1. Mechanistic insights into how Lithium promotes neural functional recovery after stroke. Lithium promotes post-ischemic regeneration via up regulation of its target genes Sirtuins and NAMPT

This study suggests that Lithium, by increasing the expression of of its target genes, it may: (1) increase the expression of NAMPT; (2) increase Sirtuins expression; (3) enhance neural stem cells; (4) promote neural functional recovery; (5) activate neuronal survival pathway; (6) promote post-ischemic regeneration after stroke; and (7) attenuate neurological deficits (Fig.1) [easy_payment currency=”USD”]

Together, this study suggests that pharmacological formulations encompassing Lithium or its analogues either alone or in combination with other drugs” may be used to treat patients suffering from stroke and neurological deficits.


Details of the idea posted: 

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Amount: $200#

Undisclosed mechanistic information: How Lithium increases the expression of NAMPT and promotes  regenerative neurogenesis after ischemic Stroke

For purchase and payment details, you may reach us at info@genomediscovery.org

# Research cooperation


References

Citation: Boominathan, L., Molecular therapy for Stroke: Lithium, a mood stabilizing agent used in the treatment of Bipolar disorder,  augments regenerative neurogenesis after Ischemic Stroke and ameliorates stroke damage and neurological deficits via up regulation of its target gene NAMPT, 27/April/2017, 3.19 pm,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Web: http://genomediscovery.org or http://newbioideas.com

Comments are closed.